Johnson & Johnson Q2: Solid (If Not Spectacular) Performance Satisfies Wall Street
AI Summary
Johnson & Johnson reported solid Q2 financial results that satisfied Wall Street expectations, though not showing spectacular growth. This performance reflects steady demand in healthcare products and pharmaceuticals.